New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
08:27 EDTA, GENEGenetic Technologies says Agilent denied motion to dismiss patent suit
Genetic Technologies (GENE) announced that the United States District Court for the Northern District of California has last week issued an Order denying a motion brought by Agilent Technologies (A) to dismiss the patent infringement law suit brought against it by GTG. This action was initially brought by GTG against Agilent in 2011, in the District Court of Colorado, but was then moved at the request of Agilent to the District Court in the Northern District of California. GTG Acting CEO Tom Howitt repeated: “With the removal of what some potential licensees have apparently used as a reason to delay settlement discussions, we trust that good faith negotiations will now resume in earnest.”
News For GENE;A From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
11:02 EDTAAgilent announces strategic collaboration with National University of Singapore
Subscribe for More Information
April 22, 2015
16:15 EDTAAgilent announces resolution to FDA warning letter for Dako Denmark
Subscribe for More Information
April 21, 2015
08:51 EDTAJPMorgan life sciences analyst holds an analyst/industry conference call
Subscribe for More Information
April 20, 2015
09:18 EDTGENEOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Morgan Stanley (MS), up 2.1%... Cliffs Natural (CLF), up 1.3%... Check Point Software (CHKP), up 1.1%. ALSO HIGHER: Genetic Technologies (GENE), up 28.2% after additional health centers to offer BREVAGenplus... Hanwha Q Cells (HQCL), up 16.2% following solar module supply agreement with NextEra Energy (NEE)... Provectus (PVCT), up 6.7% after receiving notice of allowance for PV-10 combined with other drugs. DOWN AFTER EARNINGS: Royal Caribbean (RCL), down 6.1%... FARO (FARO), down 16.4%. ALSO LOWER: Yandex (YNDX), down after Barron's recommends that investors take some profits... Carnival (CCL), down 2% after Royal Caribbean reported quarterly results.
05:33 EDTGENEGenetic Technologies announces additional health centers to offer BREVAGenplus
Genetic Technologies announced that a further two new breast health centres will begin to offer BREVAGenplus to their at-risk patients in a systematic fashion. This is in addition to the six breast health centres that the company previously announced were set to adopt BREVAGenplus, of which all six have in fact provided samples during the March 2015 quarter. The company reiterates that it expects sales growth to accelerate in the second half of calendar 2015 and beyond. The company believes that the adoption of BREVAGenplus by a total of eight new breast health centres validates the company's recently re-focused sales and marketing strategy, announced in September 2014, whereby the Company shifted its focus to these large facilities. While these centres are more complex entities with longer sales cycles, they offer higher and more stable long-term revenue potential. The company is working closely with these pivotal breast health centres and referring health care practitioners to ensure the creation of a personalised comprehensive breast cancer risk assessment approach in which BREVAGenplus plays an integral role. In this way, the company aims to reinforce the benefits of the test, ease its adoption by the new clinics and ensure its routine use by them.
April 19, 2015
14:47 EDTAMerck submits supplemental biologics license for Keytruda in lung cancer
Subscribe for More Information
April 13, 2015
16:18 EDTAeBay announces executive appointments ahead of PayPal separation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use